SCHEMBL8659052

SCHEMBL8659052

CCOC(=O)CCc1c[nH]c2cnc(-n3cncn3)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTR1A P08908 2/20 0.41
HTR2C P28335 2/20 0.41
PIM1 P11309 1/20 0.39
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
MAPT P10636 5/20 0.37
HSP90AA1 P07900 1/20 0.37
HTT P42858 1/20 0.37
KDM4E B2RXH2 1/20 0.36
PKM P14618 1/20 0.36
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8424904 0.85 PIM1 (0.46) CYP2C19HTR1AHTR2CPIM1MTNR1A
SCHEMBL8664685 0.83 SMN1; SMN2 (0.46) SMN1; SMN2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL8644915 0.79 PIM1 (0.47) SMN1; SMN2CYP2C9HTR1AHTR2CPIM1
SCHEMBL8650036 0.75 HTR1A (0.51) CYP1A2CYP3A4CYP2D6CYP2C19HTR1A
SCHEMBL8662360 0.73 HTR1D (0.42) HTR1AMAPTHTR1DHTR1BLMNA
SCHEMBL8646055 0.73 PIM1 (0.46) HTR1AHTR2CPIM1MAPTADRA2C
SCHEMBL8662842 0.71 HTR1D (0.53) HTR1AHTR2CPIM1HTR1DHTR1B
SCHEMBL15245742 0.70 SMN1; SMN2 (0.61) SMN1; SMN2CYP1A2CYP3A4CYP2D6CYP2C9
Oxalic Acid SCHEMBL8659656 0.69 HTR1D (0.54) PIM1HTR1DHTR1B
SCHEMBL853660 0.69 CYP2D6 (0.60) SMN1; SMN2CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807857-A Piperazine, piperidine and tetrahydropyridine derivative of indol-3-alkyl as 5-HT1D-α agonists MERCK SHARP & DOHME LTD. (GB) 1998-09-15 US disclosed